This article discusses the integration of genomic sequencing and microbiome testing in cancer treatment, emphasizing their combined potential to enhance personalized care. It highlights how these technologies inform treatment decisions, optimize therapy responses, and mitigate side effects. The evolving research supports a nuanced approach in oncology, promising improved patient outcomes.
